A presentation and Q&A session with Dr. Susanne Danhauser-Riedl, 4SC’s Chief Medical Officer, and experts Professor Dr. Rudolf Stadler and Professor Julia Scarisbrick, on the landmark positive RESMAIN study data that could significantly change current clinical practice in the treatment of advanced CTCL.

Share this page:

Follow us on: